AI-Generated Question Prompts for Lymphoma and Multiple Myeloma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how AI-generated question lists, known as GPT-QPL, can help patients with blood cancers, such as lymphoma and multiple myeloma, communicate more effectively with their doctors. The focus is on creating personalized questions for patients to ask during appointments, aiming to improve the information they receive and their confidence in discussions. Patients diagnosed with lymphoma or multiple myeloma who have a follow-up appointment scheduled at a participating clinic might be suitable candidates. Participants will use these AI-generated question lists during visits to assess the impact on communication and satisfaction with care. As an unphased trial, this study offers a unique opportunity to enhance communication skills and satisfaction with care.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using AI to help with questions during appointments, so it's unlikely to require changes to your medication.
What prior data suggests that this AI-generated question prompt list is safe for patients with hematologic cancers?
This study does not test any treatments on the body. Instead, it uses a list of questions created by artificial intelligence (AI) to assist patients during doctor visits. As a result, there are no safety risks typically associated with new drugs or medical devices.
Research has shown that AI tools, like ChatGPT, can sometimes struggle to provide complete answers to specific medical questions. However, this does not pose any physical risk to patients. The main goal is to determine if these AI-generated questions can enhance patient-doctor communication and help patients feel more informed about their care.
Overall, this trial focuses on improving communication, not testing a medicine or procedure. Therefore, participants face no physical safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about the AI-generated Question Prompt List (GPT-QPL) because it offers a personalized communication tool that could significantly enhance doctor-patient interactions for those with lymphoma and multiple myeloma. Unlike traditional treatments that focus primarily on managing the disease itself, GPT-QPL aims to empower patients by helping them ask more informed questions, potentially leading to better understanding and management of their condition. This innovative approach leverages artificial intelligence to tailor question prompts to each patient's specific needs, promoting more meaningful conversations and informed decision-making in medical appointments.
What evidence suggests that this AI-generated question prompt list is effective for hematologic cancers?
Research has shown that AI-generated personalized question lists can assist patients with blood cancers, such as lymphoma and multiple myeloma, during doctor visits. In this trial, participants will receive the AI-Generated, Personalized Question Prompt List (GPT-QPL) to aid them. Studies have found that AI tools, like ChatGPT, create helpful and accurate question lists for patients. These lists increase patients' confidence and satisfaction with the information from their doctors. Evaluations of AI tools in healthcare have demonstrated their ability to generate relevant questions that enhance communication between patients and doctors. While early results are promising, ongoing research continues to explore how these AI-generated prompts can improve patient outcomes over time.46789
Who Is on the Research Team?
Jessica Hahne, MA, MPH
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for patients with hematologic cancers like lymphoma or multiple myeloma. Participants should be interested in using an AI tool to generate personalized questions for their doctor's appointments. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions and agree to the study procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive an AI-generated, personalized question prompt list tailored to their individual characteristics and concerns
Follow-up
Participants are monitored for changes in communicative self-efficacy and satisfaction with information received
What Are the Treatments Tested in This Trial?
Interventions
- GPT-QPL
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor